Preeclampsia - Searching for the Cause

New England Journal of Medicine

Volumn 350, Issue 7, 2004, Pages 641-642

  Solomon, Caren G ^b   Seely, Ellen W ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

DISEASE ASSOCIATION; HYPERTENSION; PATHOGENESIS; PATHOPHYSIOLOGY; PREECLAMPSIA; PREGNANCY; PRIORITY JOURNAL; PROTEINURIA; REVIEW; RISK FACTOR; BLOOD; FEMALE; HUMAN; NOTE;

PLACENTA PROTEIN; PRODUCT PLACENTA GROWTH FACTOR; VASCULOTROPIN RECEPTOR 1;

FEMALE; HUMANS; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY PROTEINS; RISK FACTORS; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1;

EID: 1642279635     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJMp038241     Document Type: Review

References (3)

1. Caritis S, Sibai B, Hauth J, et al. Low-dose aspirin to prevent preeclampsia in women at high risk. N Engl J Med 1998;338:701-5.
2. Levine RJ, Hauth JC, Curet LB, et al. Trial of calcium to prevent preeclampsia. N Engl J Med 1997;337:69-76.
3. Maynard SE, Min J-Y, Merchan J, et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 2003;111:649-58.